Compounds > 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone
Page last updated: 2024-11-03

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Vascular Injuries

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with Vascular Injuries in 1 studies

4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone: Inhibitor of phosphodiesterases.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Totani, L1
Piccoli, A1
Dell'Elba, G1
Concetta, A1
Di Santo, A1
Martelli, N1
Federico, L1
Pamuklar, Z1
Smyth, SS1
Evangelista, V1

Other Studies

1 other study available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Vascular Injuries

ArticleYear
Phosphodiesterase type 4 blockade prevents platelet-mediated neutrophil recruitment at the site of vascular injury.
    Arteriosclerosis, thrombosis, and vascular biology, 2014, Volume: 34, Issue:8

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Blood Platelets; Cyclic AMP-Dependent Prote

2014